Calypso Unveils New 4-D Localization Technology

Calypso Medical Technologies, Inc. officially launched its recently FDA 510(k) cleared Calypso 4D Localization System at ASTRO, providing a new technology for real-time target localization and tumor tracking for a variety of clinical applications.
The 4D Localization System utilizes electromagnetic technology in conjunction with Calypso’s implanted Beacon Electromagnetic Transponders, in the prostate, to provide tumor location information during external beam radiation therapy without adding ionizing radiation.